Cargando…

SARS-CoV-2: The Second Wave in Europe

Although the SARS-CoV-2 virus has already undergone several mutations, the impact of these mutations on its infectivity and virulence remains controversial. In this viewpoint, we present arguments suggesting that SARS-CoV-2 mutants responsible for the second wave have less virulence but much higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokas, Athanassios S, Kastis, George A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133165/
https://www.ncbi.nlm.nih.gov/pubmed/33939621
http://dx.doi.org/10.2196/22431
_version_ 1783695028005109760
author Fokas, Athanassios S
Kastis, George A
author_facet Fokas, Athanassios S
Kastis, George A
author_sort Fokas, Athanassios S
collection PubMed
description Although the SARS-CoV-2 virus has already undergone several mutations, the impact of these mutations on its infectivity and virulence remains controversial. In this viewpoint, we present arguments suggesting that SARS-CoV-2 mutants responsible for the second wave have less virulence but much higher infectivity. This suggestion is based on the results of the forecasting and mechanistic models developed by our study group. In particular, in May 2020, the analysis of our mechanistic model predicted that the easing of lockdown measures will lead to a dramatic second wave of the COVID-19 outbreak. However, after the lockdown was lifted in many European countries, the resulting number of reported infected cases and especially the number of deaths remained low for approximately two months. This raised the false hope that a substantial second wave will be avoided and that the COVID-19 epidemic in these European countries was nearing an end. Unfortunately, since the first week of August 2020, the number of reported infected cases increased dramatically. Furthermore, this was accompanied by an increasingly large number of deaths. The rate of reported infected cases in the second wave was much higher than that in the first wave, whereas the rate of deaths was lower. This trend is consistent with higher infectivity and lower virulence. Even if the mutated form of SARS-CoV-2 is less virulent, the very high number of reported infected cases implies that a large number of people will perish.
format Online
Article
Text
id pubmed-8133165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-81331652021-05-24 SARS-CoV-2: The Second Wave in Europe Fokas, Athanassios S Kastis, George A J Med Internet Res Viewpoint Although the SARS-CoV-2 virus has already undergone several mutations, the impact of these mutations on its infectivity and virulence remains controversial. In this viewpoint, we present arguments suggesting that SARS-CoV-2 mutants responsible for the second wave have less virulence but much higher infectivity. This suggestion is based on the results of the forecasting and mechanistic models developed by our study group. In particular, in May 2020, the analysis of our mechanistic model predicted that the easing of lockdown measures will lead to a dramatic second wave of the COVID-19 outbreak. However, after the lockdown was lifted in many European countries, the resulting number of reported infected cases and especially the number of deaths remained low for approximately two months. This raised the false hope that a substantial second wave will be avoided and that the COVID-19 epidemic in these European countries was nearing an end. Unfortunately, since the first week of August 2020, the number of reported infected cases increased dramatically. Furthermore, this was accompanied by an increasingly large number of deaths. The rate of reported infected cases in the second wave was much higher than that in the first wave, whereas the rate of deaths was lower. This trend is consistent with higher infectivity and lower virulence. Even if the mutated form of SARS-CoV-2 is less virulent, the very high number of reported infected cases implies that a large number of people will perish. JMIR Publications 2021-05-18 /pmc/articles/PMC8133165/ /pubmed/33939621 http://dx.doi.org/10.2196/22431 Text en ©Athanassios S Fokas, George A Kastis. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 18.05.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Viewpoint
Fokas, Athanassios S
Kastis, George A
SARS-CoV-2: The Second Wave in Europe
title SARS-CoV-2: The Second Wave in Europe
title_full SARS-CoV-2: The Second Wave in Europe
title_fullStr SARS-CoV-2: The Second Wave in Europe
title_full_unstemmed SARS-CoV-2: The Second Wave in Europe
title_short SARS-CoV-2: The Second Wave in Europe
title_sort sars-cov-2: the second wave in europe
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133165/
https://www.ncbi.nlm.nih.gov/pubmed/33939621
http://dx.doi.org/10.2196/22431
work_keys_str_mv AT fokasathanassioss sarscov2thesecondwaveineurope
AT kastisgeorgea sarscov2thesecondwaveineurope